在药物纳米粒子上的结构选择性多多巴胺涂层
Danna Niezni1, Dana Meron Azagury1, Maytal Avrashami1
1Department of Biomedical Engineering Technion - Israel Institute of Technology, Haifa, 32000, Israel.
ACS applied materials & interfaces
|January 26, 2026
概括
聚多巴胺 (PDA) 涂层对小分子药物具有选择性,挑战其通用粘附性. 分子结构,特别是含量,决定了PDA涂层的行为,以提高纳米粒子稳定性和药物输送.
科学领域:
- 材料科学 材料科学 材料科学
- 纳米技术纳米技术
- 药物运输 药物运输 药物运输
背景情况:
- 聚多巴胺 (PDA) 以其普遍的,基质独立的粘附特性而闻名.
- 目前的理解表明,PDA粘附受水和π-π相互作用的控制.
- PDA涂层的非特异性限制了复杂配方中的精确控制.
研究的目的:
- 为了研究小分子药物上聚多巴胺 (PDA) 涂层的选择性.
- 挑战PDA的普遍,基板独立的粘附的范式.
- 根据药物分子结构开发PDA涂层行为的预测模型.
主要方法:
- 在IR783稳定纳米颗粒中对30种化疗剂进行系统选.
- 利用Dragon分子描述器和主要组件分析来进行结构-属性关系分析.
- 开发并验证了基于含量和结合拓学的决策树模型.
主要成果:
- PDA涂层表现出显著的结构依赖的变化,与普遍粘附相矛盾.
- 基于百分比和N-C-N动机的预测模型实现了80%的分类准确性.
- PDA涂层提高了体稳定性,并减少了代表性药物的聚合 (特拉美替尼,达沙替尼),而不会影响药物释放.
- 在体内研究表明,在HCT116异种移植中,PDA涂层药物的疗效和配方稳定性得到了提高.
结论:
- PDA涂层选择性是一个以前未知的现象,是由分子结构驱动的,而不仅仅是传统的相互作用.
- 开发的计算模型使PDA涂层纳米颗粒的合理设计能够针对特定应用.
- 这一发现扩大了对PDA表面化学及其在纳米医学中的应用的理解.
相关概念视频
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
What is Natural Selection?
126.6K
Natural selection is an evolutionary process in which individuals with survival-promoting traits reproduce at higher rates. These favorable traits become more common within a population or species. Naturally selected traits initially arise via random genetic mutations. In order for selection to occur, there must be variation within a population, the trait controlling the variation must be heritable, and there must be an evolutionary advantage for variation in the trait.
126.6K
Clathrin Coated Vesicles
9.2K
Clathrin-coated vesicles use endocytosis to transport receptors and lysosomal hydrolases from the Golgi to the lysosome in the late secretory pathway. Clathrin-mediated endocytosis was the first described endocytic process, and Clathrin-coated vesicles remain one of the most well-studied transport vesicles. The molecular machinery that generates clathrin-coated vesicles comprises over 50 proteins that precisely coordinate vesicle formation. Cell surface receptors concentrated in indented sites...
9.2K
COP Coated Vesicles
17.4K
Membrane-enclosed structures called vesicles transport proteins and lipids across the cell. The vesicles derive their cargo from the plasma membrane, Golgi, ER, or endosome. Coated vesicles are spherical, protein-coated carriers with a 50–100 nm diameter that mediate bidirectional transport between the ER and the Golgi. The distribution of proteins between the ER and Golgi complex is dynamic and is maintained by different coated vesicles. Their formation is driven by the assembly of...
17.4K
Coat Assembly and GTPases
4.3K
Vesicles incorporate different coat protein subunits in different cell locations, which changes the properties of the coat, such as the shape and geometry of the transport vesicles. Thus, vesicle coat proteins also play a significant role in cargo selection.
Coat assembly depends on the local availability of phosphatidylinositol phosphates or PIPs and GTP-binding proteins. Adaptor proteins, which link the coat proteins to the membrane, bind to these PIPs and play a crucial role in controlling...
Coat assembly depends on the local availability of phosphatidylinositol phosphates or PIPs and GTP-binding proteins. Adaptor proteins, which link the coat proteins to the membrane, bind to these PIPs and play a crucial role in controlling...
4.3K
Pinching-off of Coated Vesicles
4.0K
Vesicle budding is orchestrated by distinct cytosolic proteins such as adaptor proteins, coat proteins, and GTPases. To initiate vesicle budding, membrane-bending proteins containing crescent-shaped BAR domains bind to the lipid heads in the bilayer and distort the membrane to form a protein-coated vesicle bud. Adaptors proteins such as AP2 for clathrin-coated vesicles can nucleate on the deformed membrane. Finally, coat proteins such as clathrin or COPI and COPII assemble into a coat forming...
4.0K


